Bookmark Article
Washington — Pfizer has agreed to lower prices on some medications for Medicaid, coinciding with the White House’s announcement of “TrumpRX,” a direct-to-consumer drug purchasing website. This initiative follows President Trump’s executive order aimed at aligning U.S. drug prices with those in other high-income countries, amid ongoing tensions with Democrats over health care funding and costs.
